Translabyrinthine microsurgical resection of small vestibular schwannomas

• Published in: Journal of neurosurgery Vol. 129; no. 1; p. 128
• Main Authors: Schwartz, Marc S, Lekovic, Gregory P, Miller, Mia E, Slattery, William H, Wilkinson, Eric P
• Format: Journal Article
• Language: English
• Published: United States 01.07.2018
• Subjects: TL = translabyrinthine; CSF = cerebrospinal fluid; PTA = pure-tone average; CPA = cerebellopontine angle; intracanalicular; microsurgery; translabyrinthine; IAC = internal auditory canal; HB = House-Brackmann; cerebellopontine angle; QOL = quality of life; AAO-HNS = American Academy of Otolaryngology–Head and Neck Surgery; VS = vestibular schwannoma; vestibular schwannoma; WRS = word recognition score
• ISSN: 1933-0693
• DOI: 10.3171/2017.2.JNS162287

OBJECTIVE Translabyrinthine resection is one of a number of treatment options available to patients with vestibular schwannomas. Though this procedure is hearing destructive, the authors have noted excellent clinical outcomes for patients with small tumors. The authors review their experience at a tertiary acoustic neuroma referral center in using the translabyrinthine approach to resect small vestibular schwannomas. All operations were performed by a surgical team consisting of a single neurosurgeon and 1 of 7 neurotologists. METHODS Data from a prospectively maintained clinical database were extracted and reviewed. Consecutive patients with a preoperative diagnosis of vestibular schwannoma that had less than 1 cm of extension into the cerebellopontine angle, operated on between 2008 and 2013, were included. Patents with neurofibromatosis Type 2, previous treatment, or preexisting facial weakness were excluded. In total, 107 patients were identified, 74.7% of whom had poor hearing preoperatively. RESULTS Pathologically, 6.5% of patients were found to have a tumor other than vestibular schwannoma. Excluding two malignancies, the tumor control rates were 98.7%, as defined by absence of radiographic disease, and 99.0%, as defined by no need for additional treatment. Facial nerve outcome was normal (House-Brackmann Grade I) in 97.2% of patients and good (House-Brackmann Grade I-II) in 99.1%. Complications were cerebrospinal fluid leak (4.7%) and sigmoid sinus thrombosis (0.9%), none of which led to long-term sequelae. CONCLUSIONS Translabyrinthine resection of small vestibular schwannomas provides excellent results in terms of complication avoidance, tumor control, and facial nerve outcomes. This is a hearing-destructive operation that is advocated for selected patients.